Cut-off values of prostate specific antigen density - an effective screening marker before prostate Biopsy

Zujaja Hina Haroon; Qamar Bashir; Azka Haroon; Usama Bin Khalid

No Detail Found!

Cut-off values of prostate specific antigen density - an effective screening marker before prostate Biopsy

Author(s)

Zujaja Hina Haroon Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan

Qamar Bashir Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan

Azka Haroon Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan

Usama Bin Khalid Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan

Abstract

OBJECTIVE: To determine cut-off values for prostate specific antigen density (PSAD) in diagnosing prostate carcinoma in symptomatic patients. METHODS: This cross sectional, observational study conducted at Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan from June 2020 to May 2021. Symptomatic patients (309) having prostatic enlargement on ultrasound were selected through consecutive sampling. All the patients underwent prostate biopsy for histopathological diagnosis. Prostate specific antigen density was calculated and compared between different age groups and different diseases. ROC curve was constructed and area under the curve was calculated to find out cut-off values value for PSAD. Sensitivity, specificity and accuracy were calculated at the cut-off values. RESULTS: Among 309 patients of median age was 68 years (IQR 43 75). There was a significant difference of PSAD in different age groups (p<0.001) and diseases like prostate carcinoma, benign prostatic hyperplasia and other prostatic disorders. PSAD had AUC of 0.878 at cut-off value of 0.135 ng/ml where sensitivity was 100%. A higher cut-off 0.20 ng/ml was suggested in younger age group as compared to the old age group where cut-off was found 0.135. CONCLUSION: Using PSAD as part of evaluation profile for prostate lesion, number of unnecessary biopsies can be significantly decreased. PSAD cut-off to aid in decision of invasive prostate biopsy is suggested to be 0.135 ng/ml with close biochemical follow up afterwards.

Publication Details

Page(s) 16-20

DOI DOI not available

Published Journal: Khyber Medical University Journal, Volume: 14, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords

Sensitivity and Specificity (MeSH), Prostate specific antigen density (Non-MeSH), Prostate (MeSH), Prostate-Specific Antigen (MeSH), Prostatic Neoplasms (MeSH), Prostatic Hyperplasia (MeSH), Cut-off (Non-MeSH)

Citations

Downloads

Views